Results 161 to 170 of about 664,100 (294)
CD161 is identified as a novel inhibitory receptor on bone marrow (BM)‐resident CD8⁺ T cells in multiple myeloma (MM). Through interaction with its ligand CLEC2D, CD161 impairs T‐cell function and promotes immune suppression. Blockade of CD161 restores tissue residency and cytotoxicity of CD8⁺ T cells and enhances chimeric antigen receptor T‐cell (CAR ...
Liwen Wang +16 more
wiley +1 more source
The African Lymphoma (Burkitt Tumour): Survivals Exceeding Two Years
V. A. Ngu
openalex +1 more source
Diagnostic significance of the histologic changes in the liver and spleen in leukemia and malignant lymphoma [PDF]
Nikola D. Kostich, Henry Rappaport
openalex +1 more source
Clinical characteristics and short-term outcomes of pediatric lymphoma: a retrospective cohort study from a large tertiary hospital in a low- and middle-income country. [PDF]
Abuhalima D +5 more
europepmc +1 more source
Intracellular Mechanical Stress‐Mediated Autophagy Cell Death via Nanospikes for Cancer Treatment
Nanospikes with tunable morphology at the nanoscale induce lysosomal membrane damage by generating localized mechanical stress, activating Galectin‐3 (Gal3)‐Trim16‐mediated autophagic cell death. Finite element analysis and laser‐triggered spike ablation enable precise control of intracellular force signaling and cytotoxicity, offering a ...
Yingze Li +11 more
wiley +1 more source
Dihydrofolate Reductase from the L1210 R Murine Lymphoma
Brian L. Hillcoat +2 more
openalex +1 more source
Bilateral eyelid masses and enophthalmos as the initial manifestation of diffuse large B-cell lymphoma: a case report. [PDF]
Ibrahim T +4 more
europepmc +1 more source
Osteosarcoma is the most common primary bone tumor with limited treatment options and a terrible prognosis. This review provides a comprehensive summary of the recent development of osteoimmunomodulatory implants for post‐operative osteosarcoma treatment, of which the potential utility in evoking durable anti‐osteosarcoma immunity and accelerating bone
Yilong Dong +6 more
wiley +1 more source

